Why de-identified data sharing for research should be in the public interest
- 29 July 2025
- journal article
- Published by BMJ in Journal of Medical Ethics
- Vol. 52 (12) , 841-848
Abstract
‘Advancing the public interest’ is a criterion for de-identified data use for research via several national data platforms and biobanks. This may be referred to via cognate terms such as public benefit, public good or social value. The criterion is often adopted without it being a legal requirement. It is a legal requirement in some jurisdictions for sharing identifiable data without consent, which does not apply to de-identified data. We argue that, even in circumstances where there are few or no legal restrictions on the sharing of de-identified data, there is a sound ethical reason for platforms to nevertheless impose a public interest criterion on data sharing. We argue that a public interest test is ethically essential for justifying research use of de-identified data via government-funded platforms because (1) it allows to promote public good and to minimise potential harmful consequences of research for both individuals and groups, for example, by offering grounds to reject research that could lead to stigmatisation of marginalised populations; (2) national data platforms hold public data and are made possible by government funds, and therefore should be used to support public interests and (3) it can demonstrate trustworthiness and contribute to promoting the social licence for data platforms to operate, which is especially important for efforts to align data governance policies with public norms and expectations.Keywords
Funding Information
- Social Science Research Council (SSRC2023-SSRTG-006)
- National Research Foundation (NRF) Singapore under its National Precision Medicine Program (NPM) Phase II Funding (MOH-000588-01)
This publication has 31 references indexed in Scilit:
- Promoting Data Sharing: The Moral Obligations of Public Funding AgenciesScience and Engineering Ethics, 2024
- The Singapore National Precision Medicine StrategyNature Genetics, 2023
- Managing expectations, rights, and duties in large-scale genomics initiatives: a European comparisonEuropean Journal of Human Genetics, 2022
- Big Health Data Research and Group Harm: The Scope of IRB ReviewEthics & Human Research, 2022
- A Framework for Promoting Diversity, Equity, and Inclusion in Genetics and Genomics ResearchJAMA Health Forum, 2022
- Genomics governance: advancing justice, fairness and equity through the lens of the African communitarian ethic of UbuntuMedicine, Health Care and Philosophy, 2021
- Big Data and Public-Private Partnerships in Healthcare and ResearchAsian Bioethics Review, 2019
- Rethinking the ethical principles of genomic medicine servicesEuropean Journal of Human Genetics, 2019
- The UK Biobank resource with deep phenotyping and genomic dataNature, 2018
- Public trust and ‘ethics review’ as a commodity: the case of Genomics England Limited and the UK’s 100,000 genomes projectMedicine, Health Care and Philosophy, 2017